Susana Del Rio Gancedo

Title: Susana Del Rio Gancedo: Innovator in Pharmaceutical Science

Introduction: Susana Del Rio Gancedo is a prominent inventor based in Edinburgh, GB. Known for her significant contributions to the field of pharmaceutical sciences, she holds a patent that showcases her innovative work in the development of MAGL inhibitors.

Latest Patents: Susana has a patent titled "Crystalline forms of a MAGL inhibitor." This patent describes new crystalline forms of the MAGL inhibitor 1-(1-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)-1,8-diazaspiro[4.5]decane-8-carbonyl)-1H-pyrazole-3-carboxylic acid, or a pharmaceutically acceptable salt thereof. This work is crucial in the ongoing efforts to develop effective treatments for various medical conditions.

Career Highlights: Susana Del Rio Gancedo is a key player at H. Lundbeck A/S, where her research and development efforts contribute to the global advancements in pharmaceuticals. Through her innovative approaches, she has made a mark in her field, which is evident from her patent.

Collaborations: Throughout her career, Susana has collaborated with talented individuals such as Thomas Vetter and Martin Juhl. These partnerships illustrate the collaborative nature of research in the pharmaceutical industry and the importance of teamwork in driving innovation forward.

Conclusion: Susana Del Rio Gancedo stands out as an inventive force in the pharmaceutical sector. Her patent and collaborations highlight her commitment to advancing medical science and improving therapeutic options available to patients. As she continues to innovate, her work will undoubtedly play a significant role in the future of pharmaceutical research.